Bachem’s Post

View organization page for Bachem, graphic

27,593 followers

Presenting two essential GLP-1 analogue APIs: Liraglutide & Semaglutide Both are GLP-1 receptor agonists for treating type 2 diabetes and obesity. Marketed as a GLP-1 analogue, it provides effective weight loss and glycemic control. Our DMF are ready and listed by the FDA! What can you expect from us: ➡️ Smooth Registration Process: Our extensive experience in successfully registering highly purified synthetic peptide drugs ensures a seamless process for generic API. ➡️ ANDA Approval: Our synthesized API are ready for commercialization as a generic product after regulatory approval. 📚 Learn More: Explore Liraglutide: https://lnkd.in/giJnEVYX Explore Semaglutide: https://lnkd.in/gu8B_Apm 🌐 Stay Informed: Read our blog article on the impact of GLP-1 analogues: https://lnkd.in/gyT2xwcq 🚀 Partner with Bachem for Generic Peptide API! #GLP-1 #Obesity #Diabetes #Peptides #Genericdrugs

Bibinsha Basheer

HR Business Partner- E20 Investment Ltd | Ex-Géant, Ex-Carrefour | Ex-REDTAG.| Ex-Twenty4 | E20 Group - Global Farms | Agritek | Amsaal | FreshPick | Omooma | ADECH | Mahsool | 2U | ANJOU FRUITS ROUGES | Reaf Nursery

1mo

In your expertise, what are the differences between highly purified synthetic peptides, like those used in Liraglutide and Semaglutide, and highly purified peptides derived from snake venom, particularly in terms of their synthesis, registration process, and potential for ANDA approval?

Like
Reply

To view or add a comment, sign in

Explore topics